Genetic variants in major depressive disorder: from pathophysiology to therapy
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …
Genetic variants in major depressive disorder: from pathophysiology to therapy.
X Gonda, P Petschner, N Eszlari, D Baksa, A Edes… - 2019 - cabidigitallibrary.org
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …
Genetic variants in major depressive disorder: From pathophysiology to therapy
X Gonda, P Petschner, N Eszlari… - Pharmacology & …, 2019 - pubmed.ncbi.nlm.nih.gov
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …
Genetic variants in major depressive disorder: From pathophysiology to therapy
X Gonda, P Petschner, N Eszlári, D Baksa… - Pharmacology and …, 2018 - real.mtak.hu
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …
[PDF][PDF] P&T 23274
X Gonda, P Petschner, N Eszlari, D Baksa, A Edes… - 2018 - core.ac.uk
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …
Genetic variants in major depressive disorder: From pathophysiology to therapy
X Gonda, P Petschner, N Eszlári, D Baksa, AE Édes… - 2019 - repo.lib.semmelweis.hu
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …
Genetic variants in major depressive disorder: From pathophysiology to therapy.
X Gonda, P Petschner, N Eszlari, D Baksa… - Pharmacology & …, 2018 - europepmc.org
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …
Genetic variants in major depressive disorder: From pathophysiology to therapy
X Gonda, P Petschner, N Eszlari… - Pharmacology & …, 2018 - research.manchester.ac.uk
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …
Genetic variants in major depressive disorder: From pathophysiology to therapy
G Xénia, P Péter, E Nóra, B Dániel, ÉA Edit, P Antal… - 2019 - repo.lib.semmelweis.hu
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …
medications in major depression. The main reason behind this fact is the lack of confirmation …